A poorly regulated grey market is growing online around unapproved peptides, which are being promoted on social media for uses […]
Continue readingpharmacy
UPDATED: Funding new medicines in NZ – Expert reaction
Funding new medicines in New Zealand can take over eight years and recommending a drug as high priority does not […]
Continue readingPainkiller use high despite risks – study
The anti-inflammatory drug diclofenac, sold as Voltaren in New Zealand, has come under fire internationally for being too widely used […]
Continue readingMedication and driving – experts respond
Drugs prescribed to treat anxiety, depression and insomnia may increase patients’ risk of being involved in motor vehicle accidents, according […]
Continue reading